IL95949A - תהליך לכנת l-)-3 פירוגלוטאמיל(-l-תיאולידין -4-חומצה קרבוכסילית ותולדותיה - Google Patents

תהליך לכנת l-)-3 פירוגלוטאמיל(-l-תיאולידין -4-חומצה קרבוכסילית ותולדותיה

Info

Publication number
IL95949A
IL95949A IL9594990A IL9594990A IL95949A IL 95949 A IL95949 A IL 95949A IL 9594990 A IL9594990 A IL 9594990A IL 9594990 A IL9594990 A IL 9594990A IL 95949 A IL95949 A IL 95949A
Authority
IL
Israel
Prior art keywords
acid
derivatives
thiazolidine
formula
carboxylic acid
Prior art date
Application number
IL9594990A
Other languages
English (en)
Other versions
IL95949A0 (en
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Publication of IL95949A0 publication Critical patent/IL95949A0/xx
Publication of IL95949A publication Critical patent/IL95949A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL9594990A 1989-10-12 1990-10-10 תהליך לכנת l-)-3 פירוגלוטאמיל(-l-תיאולידין -4-חומצה קרבוכסילית ותולדותיה IL95949A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22003A IT1239029B (it) 1989-10-12 1989-10-12 Processo per la preparazione dell'acido 3-(l-piroglutamil)-l- tiazolidin-4-carbossilico e suoi derivati.

Publications (2)

Publication Number Publication Date
IL95949A0 IL95949A0 (en) 1991-07-18
IL95949A true IL95949A (he) 1995-10-31

Family

ID=11190043

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9594990A IL95949A (he) 1989-10-12 1990-10-10 תהליך לכנת l-)-3 פירוגלוטאמיל(-l-תיאולידין -4-חומצה קרבוכסילית ותולדותיה

Country Status (18)

Country Link
US (1) US5110936A (he)
EP (1) EP0422566B1 (he)
JP (1) JP2813450B2 (he)
KR (1) KR100195895B1 (he)
AT (1) ATE121420T1 (he)
AU (1) AU644379B2 (he)
CA (1) CA2027341C (he)
DE (2) DE422566T1 (he)
DK (1) DK0422566T3 (he)
ES (1) ES2028766T3 (he)
FI (1) FI95271C (he)
GR (1) GR910300072T1 (he)
HU (1) HU210213B (he)
IE (1) IE67047B1 (he)
IL (1) IL95949A (he)
IT (1) IT1239029B (he)
NO (1) NO178028C (he)
ZA (1) ZA908097B (he)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230706B (it) * 1989-02-10 1991-10-29 Poli Ind Chimica Spa Derivati dell'acido 3 piroglutamoil tiazolidin 4 carbossilico e loro proprieta' farmacologiche.
IT1237998B (it) * 1990-01-23 1993-06-21 Poli Ind Chimica Spa Acido 3-l-(5-tioxo-l-prolil)tiazolidin-4-carbossilico e derivati, loro preparazione e composizioni farmaceutiche che li contengono
IT1270017B (it) * 1994-09-27 1997-04-16 Poli Ind Chimica Spa "sintesi quantitativa dell'acido 3-(l-piroglutamil)-l-tiazolidin-4- carbossilico e suoi derivati"
WO1998009955A1 (en) * 1996-09-06 1998-03-12 Eli Lilly And Company Process and novel intermediates
JP2010537984A (ja) * 2007-08-28 2010-12-09 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ ポリペプチドおよび蛋白質の化学合成のための方法および中間体
CN102167727B (zh) * 2011-01-29 2013-05-15 浙江金立源药业有限公司 一种匹多莫德的合成方法
WO2016112977A1 (en) 2015-01-15 2016-07-21 Polichem S.A. Di-pidotimod benzathine and solid forms thereof
KR101642445B1 (ko) * 2016-01-11 2016-07-26 (주)남양통신 수상태양광 발전장치용 계류장치
CN107383162A (zh) * 2017-07-06 2017-11-24 成都美域高制药有限公司 一种匹多莫德的制备方法
CN108640912A (zh) * 2018-06-19 2018-10-12 广州大光制药有限公司 一种匹多莫德的工业化规模制备方法
CN111233854A (zh) * 2019-12-30 2020-06-05 常州寅盛药业有限公司 一种匹多莫德杂质的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202426B (it) * 1987-01-26 1989-02-09 Poli Ind Chimica Spa Derivato di acido tiazolidin-4-carbossilico,sua preparazione e composizioni farmaceutiche che lo contengono

Also Published As

Publication number Publication date
ES2028766T1 (es) 1992-07-16
JPH03193799A (ja) 1991-08-23
IT1239029B (it) 1993-09-20
FI95271B (fi) 1995-09-29
EP0422566B1 (en) 1995-04-19
KR910007923A (ko) 1991-05-30
ATE121420T1 (de) 1995-05-15
DE422566T1 (de) 1991-09-05
HUT59136A (en) 1992-04-28
NO904404L (no) 1991-04-15
IE903599A1 (en) 1991-04-24
JP2813450B2 (ja) 1998-10-22
AU644379B2 (en) 1993-12-09
NO178028C (no) 1996-01-10
ES2028766T3 (es) 1995-07-01
GR910300072T1 (en) 1991-11-15
NO178028B (no) 1995-10-02
ZA908097B (en) 1991-08-28
DE69018755D1 (de) 1995-05-24
EP0422566A1 (en) 1991-04-17
KR100195895B1 (ko) 1999-06-15
NO904404D0 (no) 1990-10-11
DE69018755T2 (de) 1995-08-24
CA2027341C (en) 2007-10-02
HU210213B (en) 1995-02-28
IL95949A0 (en) 1991-07-18
FI905011A0 (fi) 1990-10-11
DK0422566T3 (da) 1995-06-26
IT8922003A1 (it) 1991-04-12
HU906417D0 (en) 1991-04-29
US5110936A (en) 1992-05-05
CA2027341A1 (en) 1991-04-13
AU6452190A (en) 1991-04-18
IE67047B1 (en) 1996-02-21
FI95271C (fi) 1996-01-10
IT8922003A0 (it) 1989-10-12

Similar Documents

Publication Publication Date Title
US4978673A (en) Organic salts of physostigmine derivatives
US4136101A (en) Process for preparing dialkyl (p-aminobenzoyl) glutamates
DE60220877T2 (de) Verfahren zur Herstellung von hochreinem Perindopril und Zwischenverbindungen nützlich in der Synthese
IL95949A (he) תהליך לכנת l-)-3 פירוגלוטאמיל(-l-תיאולידין -4-חומצה קרבוכסילית ותולדותיה
US4857656A (en) Active esters used for production of esters or amides and process for producing esters or amides
EP0950664B1 (en) Process for producing N-glycyltyrosine
SU882409A3 (ru) Способ получени галоидзамещенных меркаптоациламинокислот
US3856848A (en) Process for preparing a protected arginine
US4490386A (en) Phosphate salts of 1-[2-[(1-alkoxycarbonyl-3-aralkyl)-amino]-1-oxoalkyl]octahydro-1H-indole-2-carboxylic acids, preparation of, and medical compositions thereof
JPH02306947A (ja) キラルβ―アミノ酸の製造方法
US5686627A (en) Sodium enalapril complex and the use thereof to make sodium enalapril
JP4097291B2 (ja) 置換バリンアミド誘導体の製造方法
US6031112A (en) Process for the production of alkoxycarbonyl-dipeptides intermediates in the synthesis of the lisinopril
JPH01290658A (ja) スルホニウム化合物の製造方法
US3903077A (en) Direct synthesis of dopamine amino acid amides
DE69821483T2 (de) Verfahren zur gewinnung von chinaprylhydrochlorid und solvaten, die bei der isolierung und reinigung von chinaprylhydrochlorid nützlich sind
US5216125A (en) Active ester used for production of acylated amino acids
EP0331988A1 (en) Sulfonium compounds, as well as process for producing active esters and amides used for the production of amides
KR950009316B1 (ko) 피롤리딘카르복실산 유도체의 제조방법
US5929242A (en) Manufacture of levobupivacaine and analogues thereof from L-lysine
JPH078853B2 (ja) ドーパミン誘導体の製法
MXPA03001310A (es) Preparacion de sales de fosfonio sustituidas con 3-pirrolidin-lactama n-protegida.
DE2022032C3 (de) Verfahren zur Herstellung von Pepliden
EP0040435A1 (en) Peptide derivatives and process for the preparation thereof
KR20190056296A (ko) 의약품 합성용 중간체 화합물의 제조 방법

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees